orapharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /EPiServer/CMS/ Disallow: | ||
Meta Tags
| Title | Improving Oral Health and Overall Health | OraPharma |
| Description | Together we make healthy smiles OraPharma is focused on improving patient's lives through the connection between oral health and overall |
| Keywords | orapharma |
Server Information
| WebSite | |
| Host IP | 45.60.82.248 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
orapharma.com Valuation
|
US$9,940,927
Last updated: 2023-05-03 02:09:21
orapharma.com has Semrush global rank of 1,064,720. orapharma.com has an estimated worth of US$ 9,940,927, based on its estimated Ads revenue. orapharma.com receives approximately 1,147,030 unique visitors each day. Its web server is located in United States, with IP address 45.60.82.248. According to SiteAdvisor, orapharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$9,940,927 |
| Daily Ads Revenue | US$9,177 |
| Monthly Ads Revenue | US$275,288 |
| Yearly Ads Revenue | US$3,303,447 |
| Daily Unique Visitors | 76,469 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| orapharma.com. | A | 3599 | IP: 45.60.82.248 |
| orapharma.com. | A | 3599 | IP: 45.60.73.248 |
| orapharma.com. | NS | 86400 | NS Record: ns6.markmonitor.com. |
| orapharma.com. | NS | 86400 | NS Record: ns4.markmonitor.com. |
| orapharma.com. | NS | 86400 | NS Record: ns2.markmonitor.com. |
| orapharma.com. | NS | 86400 | NS Record: ns3.markmonitor.com. |
| orapharma.com. | NS | 86400 | NS Record: ns5.markmonitor.com. |
| orapharma.com. | NS | 86400 | NS Record: ns1.markmonitor.com. |
| orapharma.com. | NS | 86400 | NS Record: ns7.markmonitor.com. |
| orapharma.com. | MX | 600 | MX Record: 10 orapharma-com.mail.protection.outlook.com. |
| orapharma.com. | TXT | 3600 | TXT Record: _globalsign-domain-verification=kQxeXON0egy4P9JMIYPsCCMHOiLxgagLNTuXToOchp |
| orapharma.com. | TXT | 3600 | TXT Record: v=spf1 mx include:mktomail.com include:spf.protection.outlook.com ~all |
| orapharma.com. | TXT | 3600 | TXT Record: _globalsign-domain-verification=ht0ZrZXsYUjtg1qvNLtTN2gtgGc_FFAPfNDZtPSw02 |
| orapharma.com. | TXT | 3600 | TXT Record: MS=ms87102745 |
HtmlToTextCheckTime:2023-05-03 02:09:21
| Jump to: About Us Products Professional Education Partnerships Careers Contact us Together we make healthy smiles happen Together we make healthy smiles happen Together we make healthy smiles happen Together we make healthy smiles happen Together we make healthy smiles happen We partner with dental professionals across the continuum of care to improve oral health A history of helping people For 25 years and counting, we have been growing as a company and expanding our curated portfolio in oral health. select a year to learn more 1996 2003 2012 2014 --> 2017 2022 2021 --> ARESTIN ® (minocycline HCl) Microspheres, 1 mg OraPharma was founded as a specialty pharmaceutical company dedicated to oral healthcare. Our flagship product, ARESTIN , was approved by the FDA in 2001. Johnson & Johnson OraPharma operated as a subsidiary of Johnson & Johnson. Bausch Health Companies OraPharma was acquired by Valeant Pharmaceuticals International, Inc., now known as Bausch Health Companies Inc., |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Location: https://www.orapharma.com/
Content-Length: 0
Connection: close
HTTP/1.1 200 OK
Cache-Control: public
Content-Length: 36118
Content-Type: text/html; charset=utf-8
Set-Cookie: dnn_IsMobile=False; path=/; HttpOnly
Set-Cookie: language=en-US; path=/; HttpOnly
Set-Cookie: .ASPXANONYMOUS=13T3ucnxqJMLg6L0VCBaZjDebj1A9uR7x271_UYp8BMXUrJuvDW_ZLQma9xFf7uPAB9OM3c3uQwmdoJ1iceQOfSGpxx-_JGE0fQFJ56cx5Z7mzj40; expires=Sun, 02-Jan-2022 20:08:10 GMT; path=/; HttpOnly
Set-Cookie: Analytics_VisitorId=845ac22a-1383-42c0-bbce-09423f8eb09a; expires=Wed, 24-Nov-2021 09:28:10 GMT; path=/; HttpOnly
Set-Cookie: Analytics=SessionId=196e91fb-ddc1-4c80-b25f-698068c7e24d&TabId=21862&ContentItemId=-1; expires=Mon, 25-Oct-2021 10:28:10 GMT; path=/; HttpOnly
X-UA-Compatible: IE=edge
Set-Cookie: dnn_IsMobile=False; path=/; HttpOnly
Set-Cookie: language=en-US; path=/; HttpOnly
Set-Cookie: .ASPXANONYMOUS=13T3ucnxqJMLg6L0VCBaZjDebj1A9uR7x271_UYp8BMXUrJuvDW_ZLQma9xFf7uPAB9OM3c3uQwmdoJ1iceQOfSGpxx-_JGE0fQFJ56cx5Z7mzj40; expires=Sun, 02-Jan-2022 20:08:10 GMT; path=/; HttpOnly
Set-Cookie: Analytics_VisitorId=845ac22a-1383-42c0-bbce-09423f8eb09a; expires=Wed, 24-Nov-2021 09:28:10 GMT; path=/; HttpOnly
Set-Cookie: Analytics=SessionId=196e91fb-ddc1-4c80-b25f-698068c7e24d&TabId=21862&ContentItemId=-1; expires=Mon, 25-Oct-2021 10:28:10 GMT; path=/; HttpOnly
Set-Cookie: __RequestVerificationToken=7DrfxLFDZwFT8SjIlZjdNNuyFxNH5JLdLz3dzMWDYhlN_wGStso90h3-vbub0ZDhcqfmnA2; path=/; HttpOnly
X-XSS-Protection: 1; mode=block
X-Frame-Options: SAMEORIGIN
Date: Mon, 25 Oct 2021 09:28:10 GMT
Set-Cookie: visid_incap_1843303=NyE+J04QTluhIa8+90NgpKl4dmEAAAAAQUIPAAAAAAAp/ghXNQT6PxtXaojHe4Ca; expires=Tue, 25 Oct 2022 07:52:01 GMT; HttpOnly; path=/; Domain=.orapharma.com
Set-Cookie: nlbi_1843303=OdtnINw7uHIG1/NnrrhyQgAAAADl2bFJ+7/9ey4QKNa+wAoz; path=/; Domain=.orapharma.com
Set-Cookie: incap_ses_1442_1843303=ZNFiSWbkSAC86OYdeAMDFKl4dmEAAAAAn1D+A+wK0ClSZfpLrt3jRw==; path=/; Domain=.orapharma.com
Set-Cookie: ___utmvmclBuYcYzB=VuDTxfavRcJ; path=/; Max-Age=900
Set-Cookie: ___utmvaclBuYcYzB=bksLhcS; path=/; Max-Age=900
Set-Cookie: ___utmvbclBuYcYzB=YZj
XluOualU: Tth; path=/; Max-Age=900
X-CDN: Imperva
X-Iinfo: 13-92444682-92444683 NNNN CT(22 48 0) RT(1635154089840 18) q(0 0 1 0) r(1 1) U6
|
orapharma.com Whois Information
Domain Name: ORAPHARMA.COM Registry Domain ID: 2319387_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-06-07T09:32:34Z Creation Date: 1997-07-10T04:00:00Z Registry Expiry Date: 2022-07-09T04:00:00Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.MARKMONITOR.COM Name Server: NS2.MARKMONITOR.COM Name Server: NS3.MARKMONITOR.COM Name Server: NS4.MARKMONITOR.COM Name Server: NS5.MARKMONITOR.COM Name Server: NS6.MARKMONITOR.COM Name Server: NS7.MARKMONITOR.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T13:17:42Z <<< |